15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential. To skip our analysis of the latest trends, and market activity, you can go directly to see the 5 Small-Cap Stocks w...
- Supported exchanges /
- NASDAQ /
- COGT.NASDAQ
Cogent Biosciences Inc (COGT NASDAQ) stock market data APIs
$10.52
-0.03(-0.3%)
as of September 18, 2024
Price chart is built with Anychart
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Cogent Biosciences Inc Financial Data Overview
| 10.55 | |
| 10.52 | |
| - | |
| 10.98 | |
| 10.52 | |
| 3.67-12.14 | |
| 1 155 M | |
| 109 M | |
| 0 | |
| -0.59 | |
| 0.03 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'COGT',
Type:
'Common Stock',
Name:
'Cogent Biosciences Inc',
Exchange:
'NASDAQ',
CurrencyCode:
'USD',
CurrencyName:
'US Dollar',
CurrencySymbol:
'$',
CountryName:
'USA',
CountryISO:
'US',
OpenFigi:
'BBG007DHZQR7',
ISIN:
NULL,
CUSIP:
NULL,
CIK:
'1622229',
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
'2018-03-29',
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Biotechnology',
HomeCategory:
NULL,
IsDelisted:
false,
}
Cogent Biosciences Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -242 215 008
- Earnings Per Share -2.49
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Cogent Biosciences Inc Earnings via APIs
- Latest Release 2024-08-06
- EPS/Forecast -0.56
Get Cogent Biosciences Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Cogent Biosciences Inc latest news via APIs
Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium
WALTHAM, Mass. and BOULDER, Colo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically define...
- CALENDAR OF EVENTS
- COGENT BIOSCIENCES
- INC
- NASDAQ:COGT
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
